Asahi Kasei, a diversified global company, constructed a new slitting facility for SUNFORT™ dry film photoresist (DFR) at its manufacturing site in Tainan, Taiwan, on July 3. Commercial operations are...
Japanese pharmaceutical contract development and manufacturing organization (CDMO) Peptistar has integrated Asahi Kasei’s novel forward osmosis–membrane distillation...
German battery manufacturer EAS Batteries has commercialized its ultra-high-power lithium-ion LFP cell, initially launched in March 2026. The cell incorporates Asahi Kasei’s novel acetonitrile-containing...
Asahi Kasei Life Science has acquired the license rights for a novel antibody-drug conjugate (ADC) technology from The Noguchi Institute. This modality enables precise control over the drug-to-antibody...
Panel-level packaging has gained momentum in the semiconductor industry as manufacturers pursue higher efficiency and improved yield that can support next-generation packaging processes. In response to...
Asahi Kasei Microdevices (AKM), a subsidiary of Asahi Kasei, has unveiled the AK491x series of premium audio operational amplifiers (op amps). These new devices mark a significant expansion of AKM’s...
Asahi Kasei, a diversified global company, has announced plans to streamline operations at its Mizushima Works by fiscal 2030. This press release features multimedia. View the...
Aicuris’s three antiviral assets complement Asahi Kasei’s therapy portfolio Aicuris revenue expected to reach $500 million by...
Asahi Kasei, a diversified global company, today announced the initiation of a Phase I clinical trial for AK1940, a novel peptide-based investigational compound developed to address significant unmet medical...
Asahi Kasei Microdevices Corporation (AKM), in collaboration with the Kyoto University Institute for Advanced Study, has successfully achieved laser oscillation in a 2 µm-band infrared photonic crystal...